Putting a POC Troponin to the Test - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Putting a POC Troponin to the Test

Independent verification shows strong precision and concordance with lab assays across clinical thresholds.

  • By

  • Julie Greenbaum

  • February 5, 2026

  • 3 min

Share

  • 1

    The TriageTrue point-of-care high-sensitivity troponin I assay demonstrated acceptable precision and minimal analytical interference.

  • 2

    The assay showed strong concordance with laboratory-based assays, with correlation coefficients ranging from 0.89 to 0.99.

  • 3

    Intra-assay precision coefficients of variation were reported as 25% and 12.2% at specific mean concentrations.

  • 4

    Hemolysis caused minimal interference, exceeding the manufacturer's claim, with acceptable limits met in all secondary analyzer comparisons.

  • 5

    The assay is deemed suitable for clinical use, including emergency and low-resource settings, supporting its incorporation into clinical pathways.

Original Source(s)

Putting a POC Troponin to the Test

  • by Julie Greenbaum

  • February 5, 2026

Related Content

Sex Differences Seen in Immune Cells

Single-cell analysis identified sex-biased immune-cell composition, gene expression, and genetic regulation in unstimulated blood immune cells

ApoB Goal Cost-Effective in Primary Prevention

Strategy increased quality-adjusted life-years and showed favorable cost-effectiveness vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol goals

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.